Brand Vori 200 mg contains Voriconazole, a triazole antifungal medication widely used to treat serious fungal infections. This medication is especially effective against invasive aspergillosis, esophageal candidiasis, and infections caused by Candida and other fungal pathogens. Voriconazole works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, thereby disrupting fungal growth and survival.

Indications
Brand Vori 200 mg is prescribed for:

• Invasive aspergillosis
• Candidemia in non-neutropenic patients
• Severe Candida infections in the skin, abdomen, kidney, bladder wall, and wounds
• Other serious infections caused by Scedosporium apiospermum and Fusarium spp., including cases resistant to other antifungals

Dosage and Administration
The recommended dose of Voriconazole varies based on the patient’s age, weight, and severity of infection. For adults, the typical oral dosage is 200 mg every 12 hours. Dosage adjustments may be necessary for individuals with liver or kidney impairments. Always follow your healthcare provider’s instructions for precise dosing.

Key Features

• Broad-spectrum antifungal activity
• Effective against resistant fungal strains
• Available in easy-to-administer oral tablet form

Precautions and Side Effects
Common side effects include visual disturbances, nausea, vomiting, headache, and rash. Rare but serious side effects may involve liver toxicity, cardiac arrhythmias, and photosensitivity reactions. Patients with known hypersensitivity to Voriconazole or any excipients in the formulation should avoid this medication.

Storage and Packaging
Store Brand Vori 200 mg tablets in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Each pack typically contains a blister strip of 10 tablets.

Conclusion
Brand Vori 200 mg is a reliable and effective solution for treating severe fungal infections. Always use under the guidance of a healthcare professional to ensure safety and optimal therapeutic outcomes.